About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT04875832

EMDR for Depressed People With Multiple Sclerosis

Several studies have reported high rates of depression in people with MS. Depressive symptoms represent a serious threat to quality of life and well-being. Furthermore, findings from the literature su...

Lead sponsor: Fondazione Don Carlo Gnocchi Onlus•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Fondazione Don Carlo Gnocchi Onlus

Collaborators

EMDR Europe
Catholic University of the Sacred Heart

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of relapsing-remitting or progressive MS.
•Presence of depressive symptomatology, with HADS scores \> 8, confirmed by HDRS scores (clinical interview) \> 14.
•No change of pharmacological treatment in the 3 months before the enrolment.
•Ability to communicate and to understand tasks.
•No clinical relapses or use of steroid treatment during the 4 weeks before the enrolment.
•Provided informed consent for study participation.

Exclusion Criteria

•Severe co-morbidity that would reduce life expectancy to less than one year (i.e. end-stage oncological diseases or severe cardiac dysfunction).
•Severe neuropsychological impairment evaluated with the MMSE.
•Psychosis or dissociative disorders.
•No current psychotherapy treatment
•Pregnancy.

Related studies

RECRUITINGPhase 2

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

NCT05837104 · Bipolar I Disorder, Depression, Anxiety, and more

RECRUITINGPhase 3

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

NCT07189325 · Relapsing-Remitting Multiple Sclerosis (RRMS), Anti-CD20 Therapy

Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury

NCT07663266 · Multiple Sclerosis, Spinal Cord Injury

RECRUITINGPhase 4

Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression

NCT06833788 · Postpartum Depression (PPD)

Transcranial Ultrasonic Stimulation in Treatment-resistant Depression : an Open-label Pilot Trial

NCT06085950 · Treatment Resistant Depression

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 6, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment15

Start dateMay 2021

Last updatedMay 6, 2021

Condition

Multiple Sclerosis Depression

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 6, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions